Grimmond T, Naisoro W
Grimmond and Associates Microbiology Consultants, New Zealand.
Sydney Adventist Hospital, Sydney Australia.
J Infect Prev. 2014 Sep;15(5):170-174. doi: 10.1177/1757177414543088.
A 350-bed Sydney hospital noted excessive container-associated sharps injuries (CASI) using small sharps containers and compared the effect from 2004 to 2010 of using a larger container engineered to reduce CASI. In Phase 1 (Ph1), disposable 1.4L containers (BD Australia) were carried to/from patients' rooms. In Phase 2 (Ph2), this stopped and a safety-engineered 32L reusable container (the Device; Sharpsmart, SteriHealth) was mounted in medication stations only and sharps were carried to and from patient rooms using kidney dishes. In Phase 3 (Ph3), the Device was wall-mounted in patient rooms. Sharps injuries were categorised as 'during-procedure', 'after-procedure but before disposal', 'CASI', and 'improper disposal SI'. Disposal-related SI comprised CASI plus improper-disposal SI. Injuries per 100 full-time-equivalent staff were analysed using Chi; ≤ 0.05; and relative risk and 95% confidence limits were calculated. In Ph1 (small containers) 19.4% of SI were CASI and transport injuries were zero. In Ph2 (Device in medication station) CASI fell 94.9% ( <0.001); Disposal-related SI fell 71.1% (=0.002) but transport injuries rose significantly. In Ph3 (Device in patient room) zero CASI occurred (<0.001); Disposal-related SI fell 83.1% (=0.001). Recapping SI fell 85.1% (=0.01) with the Device. The Device's volume, large aperture, passive overfill-protection and close-at-hand siting are postulated as SI reduction factors.
一家拥有350张床位的悉尼医院发现,使用小型锐器容器时与容器相关的锐器伤(CASI)过多,并比较了2004年至2010年使用一种旨在减少CASI的更大容器的效果。在第1阶段(Ph1),将一次性1.4升容器(BD澳大利亚公司)运送到患者房间并从患者房间运出。在第2阶段(Ph2),停止了这种做法,仅在配药站安装了一个经过安全设计的32升可重复使用容器(该装置;Sharpsmart,SteriHealth),并使用肾形盘将锐器运送到患者房间和从患者房间运出。在第3阶段(Ph3),该装置安装在患者房间的墙上。锐器伤被分类为“操作期间”、“操作后但在处置前”、“CASI ”以及 “不当处置锐器伤(SI)”。与处置相关的锐器伤包括CASI加上不当处置锐器伤。使用卡方检验分析每100名全职等效工作人员的受伤情况;P≤0.05;并计算相对风险和95%置信区间。在Ph1(小型容器)中,19.4%的锐器伤是CASI,运输伤为零。在Ph2(装置在配药站)中,CASI下降了94.9%(P<0.001);与处置相关 的锐器伤下降了71.1%(P=0.002),但运输伤显著增加。在Ph3(装置在患者房间)中,未发生CASI(P<0.001);与处置相关的锐器伤下降了83.1%(P=0.001)。使用该装置后,重新盖帽锐器伤下降了85.1%(P=0.01)。该装置的容量、大口径、被动防溢流保护和近在手边的位置被假定为锐器伤减少因素。